J Korean Med Assoc.  2003 Apr;46(4):357-361. 10.5124/jkma.2003.46.4.357.

Medical Treatment of Gouty Arthritis

• Park MC
• Lee SK

• KMID: 2065117
• DOI: http://doi.org/10.5124/jkma.2003.46.4.357

Abstract

Gout is a heterogenous group of diseases resulting from monosodium urate(MSU) crystal deposition in tissues or from supersaturation of uric acid in extracellular fluids. Clinical manifestations include (1) recurrent attacks of articular and periarticular inflammation; (2) accumulation of articular, osseous, soft tissue, and cartilagenous crystalline deposits; (3) uric acid calculi in urinary tract; and (4) interstitial nephropathy with renal function impairment. Gout almost always can be treated successfully and without complications. Therapeutic goals include terminating acute attack; providing rapid, safe relief of pain and inflammation; averting future attacks; and preventing such complications as formation of tophi, renal stones, and destructive arthropathy. Treatment of gout can be challenging, given that the disease frequently presents in association with other disorders; patient compliance can be difficult to achieve and the effectiveness and safety of therapies can vary widely from patient to patient. However, with early intervention, careful monitoring, and patient education, the prognosis is excellent.

Keyword

Gouty arthritis; Hyperuricemia; Medical treatment

MeSH Terms

Arthritis, Gouty*
Calculi
Crystallins
Early Intervention (Education)
Extracellular Fluid
Gout
Humans
Hyperuricemia
Inflammation
Patient Compliance
Patient Education as Topic
Prognosis
Uric Acid
Urinary Tract
Crystallins
Uric Acid

Reference

1. Putterman C, BenChetrit E, Caraco Y, Levy M. Colchicine intoxication: Clinical pharmacology, risk factors, features, and management. Semin Arthritis Rheum. 1991. 21:143–155.

2. Sandler DP, Barr R, Weinberg CR. Nonsteroidal antiinflammatory drugs and the risk for chronic renal failure. Ann Intern Med. 1991. 115:165–172.

3. Wortmann RL. Gout and hyperuricemia. Curr Opin Rheumatol. 2002. 14:281–286.

4. Fam AG, Dunne SM, Iazzitta J, Paton TW. Efficacy and safety of desensitization to allopurinol following cutaneous reaction. Arthritis Rheum. 2001. 44:231–238.

5. Perez-Reuz F, Alonso-Ruiz A, Calabozo M, Duruelo J. Treatment of gout after transplantation. Br J Rheumatol. 1998. 37:580.